ursodeoxycholic acid has been researched along with Muscular Dystrophy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carlson, CG; Lavin, J; Luo, K; Nielsen, C; Potter, R; Yu, V | 1 |
Bruemmer, K; Carlson, CG; Curtis, H; Gatti, F; Graham, KM; Malnassy, G; Millman, G; Sesti, J; Singh, R; Stefanski, C | 1 |
Balch, F; Carlson, CG; Henley, S; Kurz, J; Miles, M; Plummer, R; Rhodes, JA; Shinn, GL; Siegel, AS; Zimmerman, A | 1 |
3 other study(ies) available for ursodeoxycholic acid and Muscular Dystrophy
Article | Year |
---|---|
In vivo treatment with the NF-κB inhibitor ursodeoxycholic acid (UDCA) improves tension development in the isolated mdx costal diaphragm.
Topics: Animals; Biophysics; Diaphragm; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Contraction; Muscular Dystrophies; Ursodeoxycholic Acid | 2016 |
Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-kappaB pathway.
Topics: Animals; Collagen; Diaphragm; Female; Fibrosis; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophies; NF-kappa B; Pyrrolidines; Respiratory Muscles; Respiratory System Agents; Signal Transduction; Thiocarbamates; Transforming Growth Factor beta1; Ursodeoxycholic Acid | 2010 |
The influence of passive stretch and NF-κB inhibitors on the morphology of dystrophic muscle fibers.
Topics: Animals; Cell Membrane; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Fibers, Skeletal; Muscle Stretching Exercises; Muscular Dystrophies; NF-kappa B; Proline; Thiocarbamates; Ursodeoxycholic Acid | 2011 |